My question: why now?
I would have naturally assumed an Israel based company . . . would have done this firstly . . . like about IPO time?
Why cover your country base last?
The strategy herein (by DRIO) seems . . . strange.
Israel has . . . what . . . at least couple of 100,000 diabetics of all types <---Lets just estimate that its a true ballpark estimate figure . . . OK . . . lets further say . . . after demos of the DRIO device . . . 50% (100K) like it and want to use it, for convenience and motivational and national efficiency desires. What kind of yearly profit would that have brought to DRIO? Surely over $100K.
And, we have not even considered the religious duty to care for your own spiritual brothers and sisters needs, in a very close mono-culture association.
Not bad . . . for a start-up company to tout about.
And, being as Israel is an advanced medical care plan country and tech-smart. any clinical testing and user data would have been more than valuable to a start-up, one might ask quite plausibly . . . why did this not happen very early on?
Would not EU and USA and Japan governmental agencies, look with much favor upon such data studies of users from Israel, in making their in-country use commerical decisions approval? I certainly would.
The potential movie plot is starting to unwind herein . . . and are we being told that Israel WAITED for the DRIO mobile reader device to be tested overseas, first?
That would be analogous to proposing Israel would wait and test its ARROW Anti-Missile Defense System overseas, before it protected it own citizens from harms way?
What about all this stuff about potentially being able to read 'other bodily fluids'
medical and user testing data?
Would not such novel reading capabilities . . . kind of bring out the gold . . . by most governments and security and business interests?
